Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
Noninvasive radiofrequency sensor with machine learning may accurately measure glucose
NEW ORLEANS —A noninvasive device using a radiofrequency sensor may be able to measure glucose levels for people with diabetes in the future, according to a speaker at the AACE Annual Meeting.
Referral program boosts postpartum visits to primary care during year after delivery
Women with gestational diabetes or hypertension referred from obstetrics to a primary care provider after delivery were six times more likely to attend a visit with a PCP in the first year postpartum, data show.
Log in or Sign up for Free to view tailored content for your specialty!
AI, new technology major focus at 2024 AACE annual meeting
Looking to the future will be a key theme at the American Association of Clinical Endocrinology 2024 annual meeting with a keynote lecture focused on AI and sessions examining guidance updates and new technology.
Testosterone therapy not tied to additional metabolic benefits for older men with obesity
Testosterone therapy did not improve cardiometabolic measures for older men with obesity and hypogonadism receiving lifestyle intervention, according to findings published in The Journal of Clinical Endocrinology & Metabolism.
VIDEO: Following Life’s Essential 8 leads to ‘much better outcomes’
BOSTON — Life’s Essential 8, a campaign led by the American Heart Association, is an assortment of interventions “we can all follow” and “associated with much better outcomes,” Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.
VIDEO: Cardiovascular benefits of GLP-1 agonists ‘absolutely stunning’
BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.
VIDEO: New CVD risk algorithm incorporates social determinants of health
BOSTON — The recently launched PREVENT risk scoring algorithm has the ability to enhance the prevention and management of CVD, according to Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA.
VIDEO: Newly defined syndrome is a ‘brilliant concept’ on stages of CVD risk
BOSTON — Cardiovascular-kidney-metabolic syndrome, or CKM, is a new term endorsed by the American Heart Association that reflects the interplay of metabolic and renal conditions that drive the risk for CVD.
Important updates in cardiology from Clyde W. Yancy, MD, MSc
BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.
Celebrate a colleague through third annual Healio Honors
Healio is accepting submissions for its third annual peer-recognition program, Healio Honors.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read